Lionsgate Studios (NYSE:LION) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Lionsgate Studios (NYSE:LION) from a sell rating to a hold rating in a research report sent to investors on Saturday.

Several other analysts have also recently weighed in on the stock. Citigroup raised their target price on shares of Lionsgate Studios from $9.00 to $11.00 and gave the company a “buy” rating in a report on Monday, March 23rd. Morgan Stanley reiterated an “overweight” rating and set a $11.00 price target on shares of Lionsgate Studios in a report on Friday, February 6th. Zacks Research raised shares of Lionsgate Studios from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Wells Fargo & Company raised their price objective on shares of Lionsgate Studios from $9.00 to $12.00 and gave the company an “overweight” rating in a report on Friday, January 30th. Finally, Robert W. Baird lifted their price objective on shares of Lionsgate Studios from $12.00 to $14.00 and gave the stock an “outperform” rating in a research report on Thursday. Eight equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $10.65.

Lionsgate Studios Price Performance

Shares of NYSE LION opened at $12.46 on Friday. The company has a market cap of $3.62 billion, a price-to-earnings ratio of -14.66 and a beta of -0.48. The stock’s 50-day moving average is $9.55 and its two-hundred day moving average is $8.38. Lionsgate Studios has a 1-year low of $5.55 and a 1-year high of $12.47.

Lionsgate Studios (NYSE:LION) last announced its quarterly earnings data on Thursday, February 5th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.05). The firm had revenue of $724.30 million during the quarter, compared to analyst estimates of $706.03 million. Equities research analysts anticipate that Lionsgate Studios will post 0.08 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Lionsgate Studios

A number of institutional investors and hedge funds have recently added to or reduced their stakes in LION. Anson Funds Management LP increased its stake in Lionsgate Studios by 36.3% in the fourth quarter. Anson Funds Management LP now owns 9,556,948 shares of the company’s stock valued at $87,255,000 after purchasing an additional 2,543,352 shares during the last quarter. Jericho Capital Asset Management L.P. purchased a new stake in shares of Lionsgate Studios during the 4th quarter worth approximately $51,119,000. Broad Bay Capital Management LP boosted its holdings in shares of Lionsgate Studios by 38.7% in the 4th quarter. Broad Bay Capital Management LP now owns 5,168,008 shares of the company’s stock valued at $47,184,000 after buying an additional 1,441,700 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Lionsgate Studios by 7.2% in the 4th quarter. Geode Capital Management LLC now owns 4,920,277 shares of the company’s stock valued at $44,930,000 after buying an additional 331,025 shares in the last quarter. Finally, State Street Corp grew its position in shares of Lionsgate Studios by 3.7% in the 4th quarter. State Street Corp now owns 4,706,141 shares of the company’s stock valued at $42,967,000 after buying an additional 168,307 shares during the last quarter.

Lionsgate Studios Company Profile

Lionsgate Studios, operating under the ticker NYSE:LION, is a leading global entertainment company specializing in the production, acquisition and distribution of motion pictures, television programming and digital content. Headquartered in Santa Monica, California, and with additional operations in Vancouver, the company develops, finances and markets feature films that span a wide range of genres—from major franchise hits like The Hunger Games and John Wick to independent and specialty titles.